Faculty profile

Aldo Montano-Loza

Back to faculty

ProfessorMedicine DeptUniversity of Alberta

Aldo Montano-Loza

Professor

Medicine Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
10 publications in the last five years, latest in 2026.
Supervisor on 1 trainee award (1 CIHR), most recently in 2018.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

180

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Social determinants of health and access to Liver Transplantation in patients with hepatocellular carcinoma within a universal healthcare system: A retrospective cohort study.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis.
Transplantation reviews (Orlando, Fla.) · 2026
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitis.
NPJ digital medicine · 2025

All 14 publications

Latest funding

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate
CIHR · 2023 · Co-investigator
$2,050,829
Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate
CIHR · 2023 · Co-investigator
$512,707
Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation
CIHR · 2018 · Supervisor
$67,500

All 4 grants and awards

14 publications.

Social determinants of health and access to Liver Transplantation in patients with hepatocellular carcinoma within a universal healthcare system: A retrospective cohort study.

Moctezuma-Velazquez C, Patel K, Sharifi A, Miranda-Zazueta G, Singh N, Bhanji RA, Montano-Loza A, Abraldes JG

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2026

DOI: 10.1097/lvt.0000000000000996 PMID: 42735237

Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis.

Nguyen B, Quon S, Powar A, Montano-Loza A, Gulamhusein A, Chahal D

Transplantation reviews (Orlando, Fla.)2026

DOI: 10.1016/j.trre.2026.101024 PMID: 42035504

Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitis.

Baumgart DC, Cheng CH, Du TX, Parkes MD, Sadowski DC, Wine E, Hoentjen F, Halloran BP, Montano-Loza A, Zepeda-Gomez S, Wong K, Peerani F, Goebel R, Ross Mitchell J

NPJ digital medicine202511 citationsOpen Access

DOI: 10.1038/s41746-025-01504-6 PMID: 40234671

Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation Study.

Chappell KD, Fox M, Armstrong TS, Ajibulu L, Seow CH, Montano-Loza A, Kroeker KI, Kaplan GG, Novak K, Ma C, Ingram R, Hoentjen F, Halloran B, Peerani F, Kao D, Wong K

JMIR research protocols20252 citationsOpen Access

DOI: 10.2196/65659 PMID: 40749176

Study protocol to redefine muscle attenuation cut-offs for better prediction of mortality in patients with cirrhosis: a comprehensive post hoc validation study - a study protocol.

Di Cola S, D'Amico G, Motamedrad M, Montano-Loza A, Merli M

BMJ open2025

DOI: 10.1136/bmjopen-2024-094252 PMID: 40132832

Defining an NK Cell-enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study.

Madill-Thomsen KS, Gauthier PT, Abouljoud M, Bhati C, Bruno D, Ciszek M, Durlik M, Feng S, Foroncewicz B, Grąt M, Jurczyk K, Levitsky J, McCaughan G, Maluf D, Montano-Loza A, Moonka D, Mucha K, Myślak M, Perkowska-Ptasińska A, Piecha G, Reichman T, Tronina O, Wawrzynowicz-Syczewska M, Zeair S, Halloran PF

Transplantation2025

DOI: 10.1097/tp.0000000000005269 PMID: 39780312

Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience.

Mathuram Thiyagarajan U, Marfil-Garza B, Dajani K, Anderson B, Bigam D, Montano-Loza A, James Shapiro AM

Journal of transplantation2025

DOI: 10.1155/joot/8889823 PMID: 41293312

Performance of RETREAT Score in a Liver Transplant Program That Follows Total Tumor Volume Criteria.

Kadri R, Ma M, Montano-Loza A, Moctezuma-Velazquez C

Digestive diseases and sciences2025

DOI: 10.1007/s10620-025-09191-9 PMID: 40576717

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.

Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M, Pediatric PSC Consortium

Alimentary pharmacology & therapeutics202441 citationsOpen Access

DOI: 10.1111/apt.17936 PMID: 38462727

The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study.

Madill-Thomsen KS, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Grąt M, Jurczyk K, Klintmalm G, Krasnodębski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, Myślak M, Pączek L, Perkowska-Ptasińska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, Więcek A, Zieniewicz K, Halloran PF

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

DOI: 10.1111/ajt.16890 PMID: 34780106

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Meier-Stephenson, Vanessa; Cooper, Curtis L; Feld, Jordan J; Houghton, Michael; Richer, Lawrence P

Keywords: Adjuvanted Vaccine; Hepatitis C Virus; Peptide-Based Vaccine; Vaccine

$2,050,829

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Meier-Stephenson, Vanessa; Cooper, Curtis L; Feld, Jordan J; Houghton, Michael; Richer, Lawrence P

Keywords: Adjuvanted Vaccine; Hepatitis C Virus; Peptide-Based Vaccine; Vaccine

$512,707

Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation

SupervisorCIHR2018Fellowship - PA - Hepatology

Principal investigators: Ebadi, Maryam

Keywords: Abnormal Body Composition Phenotypes; Competing Risk Analysis; Computed Tomography; Discriminative Mortality Model; Lipidomic; Lipodystrophy; Liver Transplant Mortality; Metabolic Pathways; Proteomic; Sarcopenia

$67,500

Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases

Co-investigatorCIHR2012Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)

Principal investigators: Mason, Andrew L; Eksteen, Johannes A

Keywords: Autoimmune Hepatitis; Bioinformatics; Genetics; Genome Wide Association Study; Metabolism; Metabolomics; Metagenomics; Primary Biliary Cirrhosis; Primary Sclerosing Cholangitis; Proteomics

$12,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Aldo Montano-Loza

Research

Latest papers

Latest funding

Social determinants of health and access to Liver Transplantation in patients with hepatocellular carcinoma within a universal healthcare system: A retrospective cohort study.

Comparative waitlist mortality of autoimmune liver disease: A systematic review and meta-analysis.

Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitis.

Developing and Evaluating a Bundled Digital Tool to Improve Complex Care and Self-Management of Patients With Inflammatory Bowel Disease: Protocol for a Hybrid Effectiveness-Implementation Study.

Study protocol to redefine muscle attenuation cut-offs for better prediction of mortality in patients with cirrhosis: a comprehensive post hoc validation study - a study protocol.

Defining an NK Cell-enriched Rejection-like Phenotype in Liver Transplant Biopsies From the INTERLIVER Study.

Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience.

Performance of RETREAT Score in a Liver Transplant Program That Follows Total Tumor Volume Criteria.

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium.

The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study.

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Prognostic Value of a Prospective, Longitudinal Evaluation of Body Composition in Patients with Cirrhosis Evaluated for Liver Transplantation

Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases

Frequent collaborators

Karen Wong

Andrew Mason

Frank Hoentjen

Farhad Peerani

David Bigam

Sergio Zepeda-Gomez

Cynthia Seow

Eytan Wine

Binita Kamath

Christopher Ma

Kuan Liu

Amanda Ricciuto

Russell Greiner

Wael El-Matary

Brendan Halloran

Ellina Lytvyak

Russ Greiner

Mang Ma

Gilaad Kaplan

Dina Kao

Karen Kroeker